oral organとは 意味・読み方・使い方

LONG-TERM PRESERVATION SYSTEM FOR CULTURED SAMPLE FOR TISSUE/ORGAN REGENERATION UTILIZING STEM CELL DERIVED FROM MUCOUS MEMBRANE IN ORAL CAVITY例文帳に追加

口腔粘膜由来の幹細胞を利用した組織・器官再生用培養試料の長期保存システム - 特許庁

However, the site of contact in other than the respiratory tract, such as irritation/inflammation reaction in the digestive system in the case of oral administration of a corrosive/irritant substance, is considered to apply to other toxicity items such as skin corrosion, etc., and is not classified into the specific target organ.例文帳に追加

腐食性などの他の毒性項目に該当するものとして、特定標的臓器には分類しない。 - 経済産業省

However, the site of contact in other than the respiratory tract, such as irritation/inflammation reaction in the digestive system in the case of oral administration of a corrosive/irritant substance, is considered to apply to other toxicity items such as skin corrosion, etc., and is not classified into the specific target organ.例文帳に追加

ただし、気道以外の局所影響（site of contact）、例えば腐食性/刺激性物質を経口投与した場合の消化器系での刺激性/炎症性反応は、皮膚腐食性などの他の毒性項目に該当するものとして、特定標的臓器には分類しない。 - 経済産業省

However, the site of contact in other than the respiratory tract, such as irritation/inflammation reaction in the digestive system in the case of oral administration of a corrosive/irritant substance, is considered to apply to other toxicity items such as skin corrosion, etc., and is not classified into the specific target organ.例文帳に追加

ただし、気道以外の局所影響（site of contact）、例えば腐食性/刺激性物質を経口投与した場合の消化器系での刺激性/炎症性反応は、皮膚腐食性などの他の毒性項目でフォローしているので、特定標的臓器の分類には考慮しない。 - 経済産業省

A pharmaceutical composition for oral administration contains a suspension of medicinally-active ingredient microparticles having a mean particle diameter of 10 μm or smaller in a base oil, for prophylaxis and/or treatment of digestive organ-related diseases, wherein the medicinally-active ingredient is a compound having a poorly water-soluble p38MAP kinase inhibiting action or physiologically permissible salts thereof.例文帳に追加

消化器関連疾患の予防及び／又は治療のための平均粒径１０μｍ以下の医薬有効成分微粒子の基剤油中懸濁液を含む経口投与用の医薬組成物であって、医薬有効成分が難水溶性のｐ３８ＭＡＰキナーゼ阻害作用を有する化合物又は生理学的に許容されるその塩である医薬組成物。 - 特許庁

Propolis or its extract is used as a component of an NO synthetase inhibitor, an agent for the treatment of sepsis, endotoxin shock, cardiac failure, shock, hypotension, rheumatic inflammation, rheumatoid arthritis, arthritis deformans, ulcerous colitis, stress-related gastric ulcer, clone diseases, autoimmune diseases and tissue damages or rejection reactions after organ transplantation, and oral administration compositions, food products and pharmaceuticals containing the agent are also disclosed.例文帳に追加

プロポリス又はその抽出物を含有する一酸化窒素合成酵素阻害剤、敗血症、エンドトキシンショック、心不全、ショック、低血圧、リウマチ性炎症、慢性関節リウマチ、変形性関節炎、潰瘍性大腸炎、ストレス性胃潰瘍、クローン病、自己免疫疾患、臓器移植後の組織障害若しくは拒絶反応等の治療剤、これらを含有する経口用組成物、食品、医薬。 - 特許庁

To obtain a nutritive composition capable of feeding nourishment without restriction of dosage energy by raising rate of in vivo vitamin fullness and ameliorating the increase in blood sugar level of a patient requiring oral or enteral nutritional supply, especially a patient for digestive organ medical operation or aged person easy to fall into glucose tolerance disorder.例文帳に追加

経口あるいは経腸的な栄養補給を必要とする患者、中でも耐糖能異常に陥りやすい消化器外科手術患者や高齢者に対し、体内ビタミン充足率を上げ、それによって血糖値の上昇を緩やかにすることにより、投与エネルギーを制限することなく栄養補給が可能な栄養組成物を提供すること。 - 特許庁